Search





Search





Markets
/
Stocks
/
nasdaq-kros
/

Keros Therapeutics Inc

KROS

Add to Watchlist

10.650USD

+0.240+2.31%

Close 06/18, 16:00（ET）Quotes delayed by 15 min

210.15MMarket Cap

LossP/E TTM

Keros Therapeutics Inc

10.650

+0.240+2.31%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Keros Therapeutics Inc's Company Valuation

Currency: USD Updated: 2026-06-18

Previous score

7.27

Change

0

The current valuation score of Keros Therapeutics Inc is 7.27, ranking 244 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.21, which is -1166.95% below the recent high of 44.91 and -2536.75% above the recent low of -110.99.

P/E

Relevant data have not been disclosed by the company yet.

P/B

Relevant data have not been disclosed by the company yet.

P/S

Relevant data have not been disclosed by the company yet.

P/CF

Relevant data have not been disclosed by the company yet.

KeyAI

